Triple vs. Dual Adjuvant Therapy Following Liver Resection for HCC.

Conditions: HCC Interventions: Drug: HAIC plus PD-1 inhibitors plus lenvatinib; Drug: PD-1 inhibitors plus lenvatinib Sponsors: Chen Xiaoping Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials